Report Description

Global liver cancer therapeutics market is expected to register a CAGR of 7.54% and reach USD11 billion by 2025. Major factors attributing to the market growth include the growing geriatric population, rising prevalence of chronic diseases, and poor lifestyle choices such as frequent smoking and excessive consumption of alcohol, all of which contribute to liver cancer. Increased investment from both public and private sectors for Research & Development activities in order to find the cure for cancer coupled with the introduction of targeted therapies and vaccines is also likely to propel the demand for the global liver cancer therapeutics market.

Liver cancer is a chronic and life-threatening disease which begins in cells of liver. Most of the liver cancer patients do not show the symptoms at early stages but in advanced stages. Some of the common symptoms include loss of appetite, upper abdominal pain, nausea and vomiting and yellow discoloration of skin. According to World Cancer Research Fund, liver cancer is the sixth most common cancer across the globe. Another major reason for the increase in the liver cancer is the high increase in the incidences of HBV/HCV coinfection and cirrhosis. Therefore, scientists are working on developing more innovative drugs and therapies for liver cancer treatment. However, the market also faces some restrains. Expensive treatments as well as high investment costs in research and development might hamper further development of liver cancer therapeutics market.

The global liver cancer therapeutics market is segmented based on cancer type, therapy, equipment, age, factors, route of administration, distribution channel and region. Based on the route of administration, the market is segmented into oral, intravenous and others. The oral segment is anticipated to dominate the global liver cancer therapeutics market holding a market share of 60.45% by 2025 as it is most preferred route of administration for chemotherapy. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. The hospital pharmacies are anticipated to dominate the market during the forecast period as the drugs are mostly purchased from the hospitals at the time of treatment. Based on therapy the market is segmented into chemotherapy and radiation therapy, immunotherapy, targeted therapy, and others. In 2019, chemotherapy and radiation therapy accounted for the largest market share of 49.83% and the segment is anticipated to dominate the market through 2025.

The onset of COVID-19 has adversely impacted the market on account of significantly lower patient footfall in private clinics and hospital OPDs. Major players operating in the global liver cancer therapeutics market include Bayer AG, Alnylam Pharmaceuticals Inc., F. Hoffmann-La Roche AG , Bristol-Myers Squibb Company, Eisai Co., Ltd. , Pfizer Inc., Exelixis, Inc., Merck, Celsion Corporation, Johnson & Johnson, Novartis International AG, Sanofi S.A., Eli Lilly and Company, Perkin Elmer, Sun Pharmaceutical Industries Ltd., AbbVie Inc., Amgen Inc., AstraZeneca, Philips Healthcare Pvt. Ltd and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and forecast the market size of global liver cancer therapeutics market.
  • To classify and forecast global liver cancer therapeutics market based on cancer type, therapy, equipment, age, factors, route of administration, distribution channel and region.
  • To identify drivers and challenges for global liver cancer therapeutics market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global liver cancer therapeutics market.
  • To conduct pricing analysis for global liver cancer therapeutics market.
  • To identify and analyze the profile of leading players operating in global liver cancer therapeutics market.

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of leading players operating across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include market players, which could not be identified due to the limitations of secondary research. TechSci Research analyzed the market players, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global liver cancer therapeutics market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Liver cancer therapeutics players and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to liver cancer therapeutics
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as market players, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global liver cancer therapeutics market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Liver Cancer Therapeutics Market, By Cancer Type:
    • Hepatocellular Carcinoma
    • Cholangiocarcinoma
    • Hepatoblastoma
    • Angiosarcoma
    • Liver Metastasis
  • Global Liver Cancer Therapeutics Market, By Therapy:

o   Targeted Therapy

o   Chemotherapy and Radiation Therapy

o   Immunotherapy

o   Others

  • Global Liver Cancer Therapeutics Market, By Equipment:
    • Computed Radiography
    • Sonography
    • MRI
    • Others
  • Market, By Age:
    • 0-18
    • 18-35
    • 35-50
    • 50+
  • Global Liver Cancer Therapeutics Market, By Factors:
    • Cirrhosis
    • Nonalcoholic Fatty Liver Disease
    • Excessive Alcohol Consumption
    • Others
  • Global Liver Cancer Therapeutics Market, By Route of Administration:
    • Oral
    • Intravenous
    • Others

·         Global Liver Cancer Therapeutics Market, By Distribution Channel:

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
  • Global Liver Cancer Therapeutics Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Australia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global liver cancer therapeutics market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of content

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Liver Cancer Therapeutics Market

4.    Voice of Customer

5.    Executive Summary

6.    Global Liver Cancer Therapeutics Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Cancer Type (Hepatocellular Carcinoma, Cholangiocarcinoma, Hepatoblastoma, Angiosarcoma, Liver Metastasis)

6.2.2.     By Therapy (Targeted Therapy, Chemotherapy and Radiation Therapy, Immunotherapy, Others)

6.2.3.     By Equipment (Computed Radiography, Sonography, MRI, Others)

6.2.4.     By Age (0-18, 18-35, 35-50, 50+)

6.2.5.     By Factors (Cirrhosis, Nonalcoholic Fatty Liver Disease, Excessive Alcohol Consumption, Others)

6.2.6.     By Route of Administration (Oral, Intravenous, Others) 

6.2.7.     By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies)

6.2.8.     By Company (2019)

6.2.9.     By Region

6.3.  Market Attractiveness Index

7.    Asia-Pacific Liver Cancer Therapeutics Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Cancer Type

7.2.2.     By Therapy

7.2.3.     By Equipment

7.2.4.     By Age

7.2.5.     By Factors

7.2.6.     By Route of Administration

7.2.7.     By Country

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Liver Cancer Therapeutics Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Cancer Type

7.3.1.2.2.             By Therapy

7.3.1.2.3.             By Equipment

7.3.1.2.4.             By Age

7.3.1.2.5.             By Factors

7.3.1.2.6.             By Route of Administration

7.3.2.     India Liver Cancer Therapeutics Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Cancer Type

7.3.2.2.2.             By Therapy

7.3.2.2.3.             By Equipment

7.3.2.2.4.             By Age

7.3.2.2.5.             By Factors

7.3.2.2.6.             By Route of Administration

7.3.3.     Japan Liver Cancer Therapeutics Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Cancer Type

7.3.3.2.2.             By Therapy

7.3.3.2.3.             By Equipment

7.3.3.2.4.             By Age

7.3.3.2.5.             By Factors

7.3.3.2.6.             By Route of Administration

7.3.4.     South Korea Liver Cancer Therapeutics Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Cancer Type

7.3.4.2.2.             By Therapy

7.3.4.2.3.             By Equipment

7.3.4.2.4.             By Age

7.3.4.2.5.             By Factors

7.3.4.2.6.             By Route of Administration

7.3.5.     Australia Liver Cancer Therapeutics Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Cancer Type

7.3.5.2.2.             By Therapy

7.3.5.2.3.             By Equipment

7.3.5.2.4.             By Age

7.3.5.2.5.             By Factors

7.3.5.2.6.             By Route of Administration

8.    Europe Liver Cancer Therapeutics Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Cancer Type

8.2.2.     By Therapy

8.2.3.     By Equipment

8.2.4.     By Age

8.2.5.     By Factors

8.2.6.     By Route of Administration

8.2.7.     By Country

8.3.  Europe: Country Analysis

8.3.1.     France Liver Cancer Therapeutics Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Cancer Type

8.3.1.2.2.             By Therapy

8.3.1.2.3.             By Equipment

8.3.1.2.4.             By Age

8.3.1.2.5.             By Factors

8.3.1.2.6.             By Route of Administration

8.3.2.     Germany Liver Cancer Therapeutics Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Cancer Type

8.3.2.2.2.             By Therapy

8.3.2.2.3.             By Equipment

8.3.2.2.4.             By Age

8.3.2.2.5.             By Factors

8.3.2.2.6.             By Route of Administration

8.3.3.     United Kingdom Liver Cancer Therapeutics Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Cancer Type

8.3.3.2.2.             By Therapy

8.3.3.2.3.             By Equipment

8.3.3.2.4.             By Age

8.3.3.2.5.             By Factors

8.3.3.2.6.             By Route of Administration

8.3.4.     Italy Liver Cancer Therapeutics Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Cancer Type

8.3.4.2.2.             By Therapy

8.3.4.2.3.             By Equipment

8.3.4.2.4.             By Age

8.3.4.2.5.             By Factors

8.3.4.2.6.             By Route of Administration

8.3.5.     Spain Liver Cancer Therapeutics Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Cancer Type

8.3.5.2.2.             By Therapy

8.3.5.2.3.             By Equipment

8.3.5.2.4.             By Age

8.3.5.2.5.             By Factors

8.3.5.2.6.             By Route of Administration

9.    North America Liver Cancer Therapeutics Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Cancer Type

9.2.2.     By Therapy

9.2.3.     By Equipment

9.2.4.     By Age

9.2.5.     By Factors

9.2.6.     By Route of Administration

9.2.7.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Liver Cancer Therapeutics Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Cancer Type

9.3.1.2.2.             By Therapy

9.3.1.2.3.             By Equipment

9.3.1.2.4.             By Age

9.3.1.2.5.             By Factors

9.3.1.2.6.             By Route of Administration

9.3.2.     Mexico Liver Cancer Therapeutics Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Cancer Type

9.3.2.2.2.             By Therapy

9.3.2.2.3.             By Equipment

9.3.2.2.4.             By Age

9.3.2.2.5.             By Factors

9.3.2.2.6.             By Route of Administration

9.3.3.     Canada Liver Cancer Therapeutics Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Cancer Type

9.3.3.2.2.             By Therapy

9.3.3.2.3.             By Equipment

9.3.3.2.4.             By Age

9.3.3.2.5.             By Factors

9.3.3.2.6.             By Route of Administration

10.  South America Liver Cancer Therapeutics Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Cancer Type

10.2.2.  By Therapy

10.2.3.  By Equipment

10.2.4.  By Age

10.2.5.  By Factors

10.2.6.  By Route of Administration

10.2.7.  By Country

10.3.              South America: Country Analysis

10.3.1.  Brazil Liver Cancer Therapeutics Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Cancer Type

10.3.1.2.2.           By Therapy

10.3.1.2.3.           By Equipment

10.3.1.2.4.           By Age

10.3.1.2.5.           By Factors

10.3.1.2.6.           By Route of Administration

10.3.2.  Argentina Liver Cancer Therapeutics Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Cancer Type

10.3.2.2.2.           By Therapy

10.3.2.2.3.           By Equipment

10.3.2.2.4.           By Age

10.3.2.2.5.           By Factors

10.3.2.2.6.           By Route of Administration

10.3.3.  Colombia Liver Cancer Therapeutics Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Cancer Type

10.3.3.2.2.           By Therapy

10.3.3.2.3.           By Equipment

10.3.3.2.4.           By Age

10.3.3.2.5.           By Factors

10.3.3.2.6.           By Route of Administration

11.  Middle East and Africa Liver Cancer Therapeutics Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Cancer Type

11.2.2.  By Therapy

11.2.3.  By Equipment

11.2.4.  By Age

11.2.5.  By Factors

11.2.6.  By Route of Administration

11.2.7.  By Country

11.3.              MEA: Country Analysis

11.3.1.  South Africa Liver Cancer Therapeutics Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Cancer Type

11.3.1.2.2.           By Therapy

11.3.1.2.3.           By Equipment

11.3.1.2.4.           By Age

11.3.1.2.5.           By Factors

11.3.1.2.6.           By Route of Administration

11.3.2.  Saudi Arabia Liver Cancer Therapeutics Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Cancer Type

11.3.2.2.2.           By Therapy

11.3.2.2.3.           By Equipment

11.3.2.2.4.           By Age

11.3.2.2.5.           By Factors

11.3.2.2.6.           By Route of Administration

11.3.3.  UAE Liver Cancer Therapeutics Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Cancer Type

11.3.3.2.2.           By Therapy

11.3.3.2.3.           By Equipment

11.3.3.2.4.           By Age

11.3.3.2.5.           By Factors

11.3.3.2.6.           By Route of Administration

12.  Market Dynamics

12.1.              Drivers

12.2.              Challenges

13.  Market Trends & Developments

14.  Competitive Landscape

14.1.              Competition Outlook

14.2.              Players Profiled (Leading Companies)

14.2.1.  AbbVie Inc.

14.2.2.  Alnylam Pharmaceuticals Inc.

14.2.3.  Amgen Inc.

14.2.4.  AstraZeneca

14.2.5.  Bayer AG

14.2.6.  Bristol-Myers Squibb Company

14.2.7.  Celsion Corporation

14.2.8.  Eisai Co., Ltd.

14.2.9.  Eli Lilly and Company

14.2.10.                Exelixis, Inc.

14.2.11.                F. Hoffmann-La Roche AG

14.2.12.                Johnson & Johnson

14.2.13.                Merck

14.2.14.                Novartis International AG

14.2.15.                Perkin Elmer

14.2.16.                Pfizer Inc.

14.2.17.                Philips Healthcare Pvt. Ltd

14.2.18.                Sanofi S.A.

14.2.19.                Sun Pharmaceutical Industries Ltd.

15.  Strategic Recommendations

16.  About Us & Disclaimer

Figures and Tables

Figure 1: Global Liver Cancer Therapeutic Market Size, By Value, 2015-2025F (USD Million)

Figure 2: Global Per Capita Health Expenditure, In USD, 2015-2019

Figure 3: Global Liver Cancer Therapeutic Market Share, By Cancer Type, By Value, 2015-2025F

Figure 4: Global Liver Cancer Therapeutic Market Share, By Therapy, By Value, 2015-2025F

Figure 5: Global Liver Cancer Therapeutic Market Share, By Equipment, By Value, 2015-2025F

Figure 6: Global Liver Cancer Therapeutic Market Share, By Age, By Value, 2015-2025F

Figure 7: Global Liver Cancer Therapeutic Market Share, By Factors, By Value, 2015-2025F

Figure 8: Global Liver Cancer Therapeutic Market Share, By Route of Administration, By Value, 2019 & 2025F

Figure 9: Global Liver Cancer Therapeutic Market Share, By Distribution Channel, By Value, 2019 & 2025F

Figure 10: Global Liver Cancer Therapeutic Market Share, By Region, By Value, 2019 & 2025F

Figure 11: Global Liver Cancer Therapeutic Market Share, By Company, By Value, 2019

Figure 12: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Cancer Type, 2020E-2025F

Figure 13: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Therapy, 2020E-2025F

Figure 14: Global Liver Cancer Therapeutics Market Size (USD Billion) & Growth Rate (%), By Region, 2020E-2025F

Figure 15: Asia-Pacific Liver Cancer Therapeutic Market Size, By Value, 2015-2025F (USD Million)

Figure 16: Asia Pacific Liver Cancer Therapeutics Market Share, By Cancer Type, By Value, 2015-2025F

Figure 17:  Asia Pacific Liver Cancer Therapeutic Market Share, By Therapy, By Value, 2015-2025F

Figure 18: Asia Pacific Liver Cancer Therapeutic Market Share, By Equipment, By Value, 2015-2025F

Figure 19: Asia Pacific Liver Cancer Therapeutic Market Share, By Age, By Value, 2015-2025F

Figure 20: Asia Pacific Cancer Therapeutic Market Share, By Factors, By Value, 2015-2025F

Figure 21: Asia Pacific Liver Cancer Therapeutic Market Share, By Route of Administration, By Value, 2019 & 2025F

Figure 22: Asia Pacific Liver Cancer Therapeutic Market Share, By Country, By Value, 2019 & 2025F

Figure 23: Japan Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 24: Japan Total Health Expenditure as a share of GDP, 2015- 2019

Figure 25: Japan Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 26: Japan Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 27: Japan Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 28: Japan Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 29: Japan Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 30: Japan Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 31: China Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 32: China Number of Health Checks, By Volume, 2012, 2015, 2017, 2019, 2020E, 2025F (Billion)

Figure 33: China Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 34: China Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 35: China Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 36: China Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 37: China Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 38: China Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 39: India Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 40: India No of Hospitalized Cases For The Treatment of Patients, 2008, 2013 & 2019

Figure 41: India Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 42: India Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 43: India Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 44: India Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 45: India Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 46: India Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 47: South Korea Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)

Figure 48: South Korea Per Capita Expenditure On Health, By Value, ‘000 USD, 2015-2020E

Figure 49: South Korea Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 50: South Korea Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 51: South Korea Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 52: South Korea Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 53: South Korea Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 54: South Korea Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 55: Australia Liver Cancer Therapeutics Market Size, By Value 2015-2025F (USD Billion)

Figure 56: Australia Enterprise Healthcare Spending, By Value (USD Billion) 2017-2021E

Figure 57: Australia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 58: Australia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 59: Australia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 60: Australia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 61: Australia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 62: Australia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 63: Europe Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)

Figure 64: Europe Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 65: Europe Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 66: Europe Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 67: Europe Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 68: Europe Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 69: Europe Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 70: Europe Liver Cancer Therapeutics Market Size, By Country, 2015-2025F

Figure 71: Germany Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)

Figure 72: Germany New Cases of Cancer, By Type, 2019

Figure 73: Germany Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 74: Germany Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 75: Germany Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 76: Germany Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 77: Germany Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 78: Germany Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 79: France Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 80: France Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 81: France Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 82: France Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 83: France Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 84: France Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 85: France Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 86: United Kingdom Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 87: United Kingdom Healthcare Spending, By Value (USD Per Capita), 2015-2018

Figure 88: United Kingdom Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 89: United Kingdom Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 90: United Kingdom Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 91: United Kingdom Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 92: United Kingdom Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 93: United Kingdom Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 94: Italy Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 95: Italy Per Capita Expenditure On Health, By Value, ‘000 USD, 2015-2020E

Figure 96: Italy Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 97: Italy Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 98: Italy Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 99: Italy Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 100: Italy Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 101: Italy Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 102: Spain Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 103: Spain Hospital Beds, By Volume, 2014–2020E

Figure 104: Spain Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 105: Spain Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 106: Spain Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 107: Spain Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 108: Spain Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 109: Spain Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 110: North America Liver Cancer Therapeutics Market Size, By Value

Figure 111: North America Health Spending Share, By Value, 2020E

Figure 112: North America Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 113: North America Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 114: North America Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 115: North America Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 116: North America Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 117: North America Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 118: North America Liver Cancer Therapeutics Market Size, By Country, 2015-2025F

Figure 119: United States Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 120: United States Healthcare Spending, By Value, 2018 -2021F (USD Per Capita)

Figure 121: United States Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 122: United States Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 123: United States Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 124: United States Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 125: United States Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 126: United States Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 127: Canada Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 128: Canada Hospital Establishments, By Region, 2019 (Units)

Figure 129: Canada Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 130:  Canada Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 131: Canada Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 132: Canada Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 133: Canada Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 134: Canada Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 135: Mexico Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 136: Mexico Promotional Mortality (Percentage of All Deaths, By Disease, 2019

Figure 137: Mexico Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 138: Mexico Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 139: Mexico Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 140: Mexico Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 141: Mexico Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 142: Mexico Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 143: South America Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)

Figure 144: South America Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 145: South America Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 146: South America Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 147: South America Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 148: South America Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 149: South America Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 150: South America Liver Cancer Therapeutics Market Size, By Country, 2015-2025F

Figure 151: Brazil Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 152: Brazil Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 153: Brazil Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 154: Brazil Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 155: Brazil Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 156: Brazil Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 157: Brazil Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 158: Argentina Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 159: Argentina, Per Capita Health Expenditure, By Sector (USD), 2020E

Figure 160: Argentina Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 161: Argentina Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 162: Argentina Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 163: Argentina Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 164: Argentina Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 165: Argentina Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 166: Colombia Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 167: Colombia Healthcare Expenditure, By Value, USD Billion, 2015-2020E

Figure 168: Colombia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 169: Colombia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 170: Colombia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 171: Colombia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 172: Colombia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 173: Colombia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 174: Middle East & Africa Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Billion)

Figure 175: Middle East & Africa Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 176: Middle East & Africa Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 177: Middle East & Africa Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 178: Middle East & Africa Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 179: Middle East & Africa Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 180: Middle East & Africa Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 181: Middle East & Africa Liver Cancer Therapeutics Market Size, By Country, 2015-2025F

Figure 182: South Africa Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 183: South Africa per Capita Health Expenditure, 2014-2016, 2019 & 2020E (USD)

Figure 184: South Africa Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 185: South Africa Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 186: South Africa Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 187: South Africa Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 188: South Africa Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 189: South Africa Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 190: Saudi Arabia Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 191: Saudi Arabia Healthcare Budget, By Value (USD Billion),2018 & 2019

Figure 192: Saudi Arabia Covid-19 Cumulative Statistics, By Value, Till 13th May 2020

Figure 193: Saudi Arabia Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 194: Saudi Arabia Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 195: Saudi Arabia Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 196: Saudi Arabia Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 197: Saudi Arabia Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 198: Saudi Arabia Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Figure 199: UAE Liver Cancer Therapeutics Market Size, By Value, 2015-2025F (USD Million)

Figure 200: UAE Healthcare Expenditure, By Value (USD Billion), 2018, 2019, 2023F & 2028F

Figure 201: UAE Covid-19 Cumulative Statistics, By Value, Till 13th May 2020

Figure 202: UAE Liver Cancer Therapeutics Market Share, By Type, By Value, 2015-2025F

Figure 203: UAE Liver Cancer Therapeutics Market Share, By Therapy, By Value, 2015-2025F

Figure 204: UAE Liver Cancer Therapeutics Market Share, By Equipment, By Value, 2015-2025F

Figure 205: UAE Liver Cancer Therapeutics Market Share, By Age, By Value, 2015-2025F

Figure 206: UAE Liver Cancer Therapeutics Market Share, By Factors, By Value, 2015-2025F

Figure 207: UAE Liver Cancer Therapeutics Market Share, By ROA, By Value, 2015-2025F

Frequently asked questions

down-arrow

down-arrow

down-arrow

down-arrow

profile

Sakshi Bajaal

Business Consultant
Press Release

Liver Cancer Therapeutics Market to Cross USD11 billion by 2025

Mar, 2021

Increasing prevalence of liver cancer and introduction of new targeted therapies to drive global liver cancer therapeutics market through 2025.